Emerging roles of neutrophil-borne S100A8/A9 in cardiovascular inflammation

Gopalkrishna Sreejit1, Ahmed Abdel Latif2, Andrew J Murphy3

  • 1Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Pharmacological Research
|September 29, 2020
PubMed

Insights

Neutrophils and their alarmins, S100A8/A9, play dual roles in heart attack recovery, causing damage but also aiding inflammation resolution. Targeting neutrophils offers potential for better heart failure therapies.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Inflammation Research

Background:

  • Elevated neutrophil counts correlate with increased risk of major adverse cardiac events (MACE), including myocardial infarction (MI) and heart failure.
  • Neutrophils contribute to cardiac damage via immune cell attraction and inflammatory mediator release.
  • Neutrophil-derived alarmins, S100A8/A9, are implicated in MI-induced inflammation and cardiac injury.

Purpose of the Study:

  • To review the dual role of neutrophil-derived S100A8/A9 in promoting inflammation and resolution post-myocardial infarction (MI).
  • To explore therapeutic strategies targeting neutrophils for ameliorating cardiac inflammation and damage.
  • To understand how neutrophils balance pro-inflammatory and resolution-promoting functions in MI.

Main Methods:

  • Review of independent studies and scientific literature.
  • Analysis of mechanisms of neutrophil-derived S100A8/A9 in cardiac inflammation and resolution.
  • Exploration of potential therapeutic targets within neutrophil pathways.

Main Results:

  • Neutrophil-derived S100A8/A9 are causally linked to inflammation and cardiac injury following MI.
  • Serum S100A8/A9 levels correlate with MACE in MI patients.
  • Neutrophils and S100A8/A9 also exhibit crucial roles in inflammation resolution, presenting a therapeutic paradox.

Conclusions:

  • Neutrophils exert both detrimental and beneficial effects in myocardial infarction, mediated partly by S100A8/A9.
  • Targeting neutrophils requires a nuanced approach to preserve beneficial functions while mitigating harmful inflammation.
  • Further understanding of neutrophil mechanisms is key to developing effective therapies for heart failure post-MI.